Browse by author
Lookup NU author(s): Dr Laura WrightORCiD
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
© 2023 Wright et al.Since their development, verbal fluency tests (VFTs) have been used extensively throughout research and in clinical settings to assess a variety of cognitive functions in diverse populations. In Alzheimer’s disease (AD), these tasks have proven particularly valuable in identifying the earliest forms of cognitive decline in semantic processing and have been shown to relate specifically to brain regions associated with the initial stages of pathological change. In recent years, researchers have developed more nuanced techniques to evaluate verbal fluency performance, extracting a wide range of cognitive metrics from these simple neuropsychological tests. Such novel techniques allow for a more detailed exploration of the cognitive processes underlying successful task performance beyond the raw test score. The versatility of VFTs and the richness of data they may provide, in light of their low cost and speed of administration, therefore, highlight their potential value both in future research as outcome measures for clinical trials and in a clinical setting as a screening measure for early detection of neurodegenerative diseases.
Author(s): Wright LM, De Marco M, Venneri A
Publication type: Article
Publication status: Published
Journal: Psychology Research and Behavior Management
Year: 2023
Volume: 16
Pages: 1691-1705
Online publication date: 05/05/2023
Acceptance date: 05/04/2023
Date deposited: 07/06/2023
ISSN (electronic): 1179-1578
Publisher: Dove Medical Press Ltd
URL: https://doi.org/10.2147/PRBM.S284645
DOI: 10.2147/PRBM.S284645
Altmetrics provided by Altmetric
